Navigation Links
Champions Oncology Reports Financial Results for the Year Ended April 30, 2012
Date:7/18/2012

HACKENSACK, N.J., July 18, 2012 /PRNewswire/ -- Champions Oncology, Inc. (OTC: CSBR), formerly Champions Biotechnology, Inc., engages in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today its financial results for the year ended April 30, 2012.

Joel Ackerman, the CEO of Champions Oncology, stated, "Fiscal 2012 was a year of great progress for the company.  We demonstrated our ability to drive significant volume growth in both sides of our business.  We continue to evolve our strategic direction to better align the strength of our technology platform with the needs of the market.  Within this new approach, we made significant progress in expanding our customer base and building a solid operational foundation for the future."

Operating revenues were $7.1 million and $6.9 million for the years ended April 30, 2012 and 2011, respectively.

Total operating expenses were $16.2 million and $12.1 million for the years ended April 30, 2012 and 2011, respectively.

Champions reported a net loss of $8.7 million, or ($0.19) per share and $3.8 million, or ($0.11) per share for the years ended April 30, 2012 and 2011, respectively.

Excluding stock based compensation of $3.3 million, Champions recognized a net loss of $5.3* million, or ($0.11*) per share, and excluding stock based compensation of $3.1 million, a net loss of $0.7* million, or ($0.02*), per share for the years ended April 30, 2012 and 2011, respectively.

During fiscal 2012, we modified our POS business strategy to focus on growing our core technology products, which includes TumorGraft implants and drug studies.  As part of this strategy, we significantly reduced the price of our core technology products to make the products affordable to a broader patient base and to accelerate the growth of our Tumorbank.  In addition, we have increased spending on sales an
'/>"/>

SOURCE Champions Oncology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
2. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
3. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
4. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
5. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
6. Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
7. Prosperous Agriculture Reports Outstanding Sales Result for First Half of 2012
8. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012
9. GeneLink Reports First Quarter 2012 Financial Results
10. Genesis Biopharma Mentioned Favorably in BioMedReports Article
11. Vermillion Reports First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... In late 2012, Dr. Sarah Hart, of ... in China about Appearance Medicine . Although Dr. Hart ... first trip to lecture in China, and quite a different ... home to 12 and 7 million people respectively. Interest in ... this point in time. As Dr. Hart passed through the ...
(Date:5/16/2013)... 16, 2013 Cambridge Healthtech Institute will ... 19-23, 2013 at the Renaissance Waterfront Hotel in Boston, ... a close-up look at the current strategies and innovations ... quality. Leaders in the field will reveal how ... biopharmaceuticals with greater specificity and efficiency. , “In this ...
(Date:5/16/2013)... 16, 2013  HealthSparq, a trusted provider of ... largest regional health plans, will debut a new ... (AHIP) Institute 2013 conference on June 13.  The ... how health insurance companies across the country are ... marketplace demands for increased healthcare transparency. ...
(Date:5/16/2013)... HAYWARD, Calif. , May 16, 2013 ... University, Beijing , and the ... www.magceutics.com ) have demonstrated a novel therapy for reversing ... brain magnesium levels, they find significant cognitive improvement in ... to demonstrate a mechanism for reversing cognitive decline for ...
Breaking Biology Technology:The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3
... Pharmaceuticals, lung,cancer diagnostic test, LC Detect(SM), has ... Medical Breakthroughs of 2007 (Due to length ... http://www.time.com/time/specials/2007/top10/article/0,30583,1686204_1686252_1690390, ,00.html) LC Detect(SM) is a simple ... cancer, even among individuals with early-stage disease. ...
... Dec. 18 Trust for America,s,Health (TFAH) today ... the,Public,s Health from Disease, Disasters, and Bioterrorism" report, ... critical areas of the,nation,s emergency health preparedness effort ... annual cuts in federal funding for state,and local ...
... Inc. (OTC,Bulletin Board: NZYM) has earned four ... accomplishments in environmental, health,safety and security (EHS&S) ... Synthetic Organic Chemical Manufacturers Association (SOCMA) and,sponsored ... are highly,regarded and demonstrate Synthetech,s level of ...
Cached Biology Technology:Panacea Pharmaceuticals' Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazine's Ten Biggest Medical Breakthroughs of 2007 2Panacea Pharmaceuticals' Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazine's Ten Biggest Medical Breakthroughs of 2007 3Panacea Pharmaceuticals' Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazine's Ten Biggest Medical Breakthroughs of 2007 4Significant Progress Made in Nation's Preparedness to Respond to Public Health Emergencies; But Gaps in Critical Areas Threaten Overall Readiness 2Significant Progress Made in Nation's Preparedness to Respond to Public Health Emergencies; But Gaps in Critical Areas Threaten Overall Readiness 3Significant Progress Made in Nation's Preparedness to Respond to Public Health Emergencies; But Gaps in Critical Areas Threaten Overall Readiness 4Significant Progress Made in Nation's Preparedness to Respond to Public Health Emergencies; But Gaps in Critical Areas Threaten Overall Readiness 5Synthetech Earns National Recognition for Performance Improvement Program 2Synthetech Earns National Recognition for Performance Improvement Program 3
(Date:5/16/2013)... fossils that are about 23 million years old ... the gobioid order, one of the most species-rich ... led by paleontologist Professor Bettina Reichenbacher from the ... of Earth and Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) ... analysis of fish fossils which they assign to ...
(Date:5/16/2013)... around the world are meeting next week in ... showcase the latest in research findings about the ... understanding the disorders that affect them., "Canada is ... will showcase the best of neuroscience research done ... President of the Canadian Association for Neuroscience. He ...
(Date:5/16/2013)... , May 16, 2013 ... report is available in its catalogue: ... & Opportunities, 2018 http://www.reportlinker.com/p01181929/Global-Biometric-Systems-Market-Forecast--Opportunities-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Security_Systems ... and old security practises such as photographs, ... growth of biometric technologies in last few ...
Breaking Biology News(10 mins):Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 37th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2Global Biometric Systems Market Forecast & Opportunities, 2018 2Global Biometric Systems Market Forecast & Opportunities, 2018 3Global Biometric Systems Market Forecast & Opportunities, 2018 4Global Biometric Systems Market Forecast & Opportunities, 2018 5Global Biometric Systems Market Forecast & Opportunities, 2018 6Global Biometric Systems Market Forecast & Opportunities, 2018 7
... awarded a consortium of universities and companies headed by biologists ... next three years to conduct basic research that will pave ... competitive alternative to gasoline for our nation,s transportation fuel. ... $3 million from a consortium of biotechnology and energy companies, ...
... the brain, scientists can alleviate the effects of disorders ... good news. But because controlling that stimulation currently ... some of its therapeutic benefits for the patient over ... part of a European consortium, is delving deep into ...
... first convincing robotic fish that shoals will accept as ... possibilities for studying fish behaviour and group dynamics, which ... management, to predict fish migration routes and assess the ... "We,ve proven it,s possible to use robotic fish to ...
Cached Biology News:DOE awards UC San Diego consortium $9 million for algal biofuels research 2A pacemaker for your brain 2Introducing Robofish: Leading the crowd in studying group dynamics 2
Buckets for 2 racks of 5 tubes, type Stago/Hitachi...
... Satellite Thermal Cycler (MBS) is ... for medium to high throughput ... the latest in satellite block ... PC control, resulting in a ...
... AccuSpot automates LC microfractionaction, spotting and preparation ... AccuSpot system, LC eluent can be accurately ... trace amounts (eg.50nl). Matrix solutions can be ... of target plated for MALDI-TOF-MS measurements. By ...
CQCS kit for etra KR 4i , (other units)....
Biology Products: